Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,300
Closed -$226K 198
2017
Q4
$226K Buy
+1,300
New +$230K ﹤0.01% 258
2017
Q1
Sell
-5,575
Closed -$815K 240
2016
Q4
$815K Buy
5,575
+2,036
+58% +$306K 0.03% 158
2016
Q3
$590K Sell
3,539
-1,586
-31% -$268K 0.04% 175
2016
Q2
$780K Sell
5,125
-13,658
-73% -$2.12M 0.05% 139
2016
Q1
$2.82M Sell
18,783
-2,364
-11% -$351K 0.11% 96
2015
Q4
$3.43M Sell
21,147
-5,584
-21% -$878K 0.25% 89
2015
Q3
$3.7M Buy
26,731
+9,259
+53% +$1.46M 0.22% 90
2015
Q2
$2.68M Buy
17,472
+6,472
+59% +$1.04M 0.16% 101
2015
Q1
$1.76M Buy
11,000
+7,000
+175% +$1.1M 0.15% 95
2014
Q4
$637K Sell
4,000
-1,500
-27% -$234K 0.05% 143
2014
Q3
$773K Buy
5,500
+500
+10% +$65.3K 0.08% 162
2014
Q2
$592K Buy
5,000
+1,670
+50% +$193K 0.07% 167
2014
Q1
$411K Buy
+3,330
New +$404K 0.05% 143

Other funds holding AMGN

Cowen Inc's AMGN Position: Q1 2018 in Review

Cowen Inc sold out of Amgen (AMGN) in Q1 2018, closing a stake of 1,300 shares — an estimated $226K sold.

Cowen Inc first reported a position in AMGN in Q1 2014 and held it in 13 quarters. The position peaked at $3.7M in Q3 2015. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Cowen Inc reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Cowen Inc sold 1,300 Amgen shares in Q1 2018, an estimated $226K.
  • Cowen Inc first reported a position in Amgen in Q1 2014 and held it in 13 quarters.
  • Cowen Inc's Amgen position peaked at $3.7M in Q3 2015.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Cowen Inc's 13F filing for Q1 2018, filed 15 May 2018.